Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation.

Oncotarget · 2015 · PMC4637326 · PMID 26305188

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

borderline significancep = 0.08so close (0.05 < p ≤ 0.1)

Then, we evaluated NRAS-mutated versus NRAS-WT (BRAF-mutated and WT/WT combined) and found a borderline significance in mean RFS after metastasectomy (NRAS-mutated versus NRAS-WT; 30 vs 53 months, p = 0.08) (Table 4 ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.